Retrophin drug to treat nervous system disorder fails late-stage study

Retrophin Inc said on Thursday its treatment for a rare neurological disorder failed to meet the main goal of improving patient's ability to conduct daily activities in a late-stage study.

GSK's long acting HIV injection gets boost from study

GlaxoSmithKline's experimental HIV injection is as effective when given every other month as monthly, according to a study, a convenience that could help the British drugmaker in its battle against a rival drug from Gilead Sciences.GSK's two-drug injection was as effective as a monthly dose of the same regimen in maintaining viral suppression at 48 weeks in a late-stage study, said ViiV Healthcare, GSK's HIV unit.

Explainer: What are the obstacles to Bayer settling Roundup lawsuits?

Bayer AG is in mediation to potentially settle thousands of U.S. lawsuits claiming that the company's Roundup weed killer causes cancer, but some legal experts said the cases raises novel questions that may prevent an easy settlement.

Plastic particles in drinking water present 'low' risk: WHO

Microplastics contained in drinking water pose a "low" risk to human health at current levels, but more research is needed to reassure consumers, the World Health Organization (WHO) said on Thursday.

U.S. imposes sanctions on three Chinese accused of fentanyl trafficking

The U.S. Treasury on Wednesday imposed sanctions on three Chinese men accused of illegally trafficking fentanyl, acting three weeks after President Donald Trump accused Beijing of reneging on pledges to stem a flood of the highly addictive synthetic opioid into the United States.

Salvadoran woman acquitted in abortion case calls for reform

Evelyn Hernandez has a message for El Salvador's president: End the criminalization of abortion in the conservative Central American country.

Fitbit targets 1 million new users with Singapore government tie-up

Fitbit Inc said on Wednesday it signed a contract with the Singapore government to provide fitness trackers and services in a health program it said could reach up to one million users.

E-cigarette firms probed over health concerns by U.S. House panel

Four dominant e-cigarette manufacturers face a probe into the health impacts of their products, as the U.S. House Energy and Commerce Committee asked on Wednesday about the firms' research and marketing practices.

Trump administration to appeal ruling blocking price disclosure for drug ads

The Trump administration is appealing a court ruling that struck down its plan to compel pharmaceutical companies to disclose wholesale prices of their drugs in televisions advertisements.

Oklahoma judge to rule on Monday in opioid lawsuit against J&J

An Oklahoma judge will rule on Monday on whether Johnson & Johnson should be held liable in a lawsuit by the state's attorney general who argues the drugmaker should be forced to pay $17 billion for fueling the opioid epidemic.

Many dermatologists need more training on African American skin and hair

(Reuters Health) - When dermatologists have training only with Caucasians, it can lead to frustration and poor care for African American patients, a new U.S. study finds.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS